This announcement is a separate document:
富邦股份：关于收购湘渝生物科技（岳阳）有限公司70%股权进展暨完成工商变更登记的公告
Hubei Forbon Technology: Announcement on the progress of the acquisition of 70% equity of Xiangyu Biotechnology (Yueyang) Co., Ltd. and completion of industrial and commercial registration changes.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated